News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

William R. Mikesell, PharmD

Advertisement

PGY1 Pharmacy Resident at Indiana University

Articles by William R. Mikesell, PharmD

No Significant Difference Between Doxycycline and Minocycline for Bone and Joint Infections

BySophia Abene,William R. Mikesell, PharmD
June 4th 2025

At MAD-ID 2025, William R Mikesell, PharmD, presented data showing 20% vs 16% treatment failure rates in doxycycline and minocycline groups.

Advertisement

Latest Updated Articles

  • No Significant Difference Between Doxycycline and Minocycline for Bone and Joint Infections
    No Significant Difference Between Doxycycline and Minocycline for Bone and Joint Infections

    Published: June 4th 2025 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Invasive Candidiasis in 2026: Harmonizing Global and US Guidance in an Era of Diagnostic and Stewardship Complexity

2

Company Launches Mold Panel to Accelerate Diagnosis of Invasive Fungal Infections

3

Donning and Doffing PPE for High-Consequence Infectious Disease Treatment

4

Lab Safety Considerations In Dealing With High-Consequence Infectious Disease

5

Valneva Withdraws its IND and BLA for its Chikungunya Vaccine

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us